Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Symbol: NASDAQ:ELOS
- CUSIP: N/A
- Web: www.syneron.com
- Market Cap: $378.64 million
- Outstanding Shares: 34,898,000
- 50 Day Moving Avg: $10.98
- 200 Day Moving Avg: $9.59
- 52 Week Range: $6.18 - $11.43
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 19.73
- P/E Growth: 0.82
- Annual Revenue: $296.29 million
- Price / Sales: 1.28
- Book Value: $5.90 per share
- Price / Book: 1.84
- EBIDTA: $13.4 million
- Net Margins: 1.04%
- Return on Equity: 3.15%
- Return on Assets: 2.34%
- Current Ratio: 2.94%
- Quick Ratio: 2.19%
- Average Volume: 824,469 shs.
- Beta: 1.1
- Short Ratio: 0.75
Frequently Asked Questions for Syneron Medical (NASDAQ:ELOS)
What is Syneron Medical's stock symbol?
Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."
How were Syneron Medical's earnings last quarter?
Syneron Medical Ltd. (NASDAQ:ELOS) announced its earnings results on Thursday, August, 4th. The company reported $0.09 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.03. The company earned $75 million during the quarter, compared to analysts' expectations of $75.72 million. Syneron Medical had a return on equity of 3.15% and a net margin of 1.04%. Syneron Medical's revenue for the quarter was up 2.0% on a year-over-year basis. During the same period last year, the business posted $0.07 EPS. View Syneron Medical's Earnings History.
Where is Syneron Medical's stock going? Where will Syneron Medical's stock price be in 2017?
3 equities research analysts have issued 1-year price objectives for Syneron Medical's stock. Their forecasts range from $7.80 to $13.00. On average, they anticipate Syneron Medical's stock price to reach $10.60 in the next twelve months. View Analyst Ratings for Syneron Medical.
What are analysts saying about Syneron Medical stock?
Here are some recent quotes from research analysts about Syneron Medical stock:
- 1. Maxim Group analysts commented, "On May 10, 2017, ELOS announced the expiration of the go-shop" period under its merger agreement with Apax Partners. During the go-shop period, ELOS engaged in an active and extensive solicitation of 59 potential bidders, which resulted in two potential bidders each negotiating and entering into a confidentiality agreement. However, they subsequently confirmed that they weren’t interested in pursuing an acquisition of ELOS. The acquisition by Apax Partners is expected to be completed during 3Q17, subject to ELOS shareholder approval and the satisfaction of other customary closing conditions." (5/12/2017)
- 2. According to Zacks Investment Research, "Syneron Medical Ltd. manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented ELOS combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative ELOS technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications. " (1/11/2017)
Who are some of Syneron Medical's key competitors?
Some companies that are related to Syneron Medical include Intersect ENT (XENT), Lantheus Holdings (LNTH), Cryolife (CRY), GenMark Diagnostics (GNMK), AxoGen (AXGN), Invacare (IVC), Exactech (EXAC), Accuray Incorporated (ARAY), Cutera (CUTR), RTI Surgical (RTIX), Corindus Vascular Robotics (CVRS), AcelRx Pharmaceuticals (ACRX), Neovasc Inc (US) (NVCN), IRIDEX (IRIX), Cogentix Medical (CGNT), T2 Biosystems (TTOO), Iradimed Corp (IRMD) and Edap Tms SA (EDAP).
Who owns Syneron Medical stock?
Syneron Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Brandes Investment Partners LP (10.51%), North Tide Capital LLC (8.57%), Camber Capital Management LLC (6.70%),
SAND GROVE CAPITAL MANAGEMENT LLP
(5.20%), Dalton Greiner Hartman Maher & Co. (4.70%) and
SAND GROVE CAPITAL MANAGEMENT LLP
(4.30%). View Institutional Ownership Trends for Syneron Medical.
Who sold Syneron Medical stock? Who is selling Syneron Medical stock?
Syneron Medical's stock was sold by a variety of institutional investors in the last quarter, including North Tide Capital LLC, Menora Mivtachim Holdings LTD., Dalton Greiner Hartman Maher & Co., TFS Capital LLC, Ameriprise Financial Inc., Renaissance Technologies LLC, Geode Capital Management LLC and Creative Planning. View Insider Buying and Selling for Syneron Medical.
Who bought Syneron Medical stock? Who is buying Syneron Medical stock?
Syneron Medical's stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Systematic Financial Management LP, Profit Investment Management LLC, Driehaus Capital Management LLC, Clough Capital Partners L P, Menta Capital LLC, Bogle Investment Management L P DE and Jane Street Group LLC. View Insider Buying and Selling for Syneron Medical.
How do I buy Syneron Medical stock?
Shares of Syneron Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Syneron Medical stock cost?
One share of Syneron Medical stock can currently be purchased for approximately $10.85.
Earnings History for Syneron Medical (NASDAQ:ELOS)Earnings History by Quarter for Syneron Medical (NASDAQ:ELOS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/15/2017||Q416||$0.03||($0.03)||$82.02 million||$82.90 million||View||Listen|
|11/9/2016||Q316||($0.02)||$0.02||$68.08 million||$71.50 million||View||Listen|
|8/4/2016||Q216||$0.06||$0.09||$75.72 million||$75.00 million||View||Listen|
|5/19/2016||Q116||$0.01||$0.04||$64.38 million||$68.70 million||View||Listen|
|2/22/2016||Q415||$0.07||$0.07||$75.56 million||$78.90 million||View||Listen|
|11/11/2015||Q315||$0.03||$0.03||$66.60 million||$62.10 million||View||Listen|
|8/4/2015||Q215||$0.06||$0.04||$70.93 million||$73.50 million||View||N/A|
|5/13/2015||Q115||$0.01||$0.02||$62.08 million||$63.40 million||View||Listen|
|2/18/2015||Q414||$0.06||$0.09||$71.42 million||$74.10 million||View||N/A|
|11/12/2014||Q314||$0.03||$0.03||$58.32 million||$60.30 million||View||N/A|
|8/6/2014||Q214||$0.07||$0.07||$63.52 million||$64.60 million||View||Listen|
|5/14/2014||Q114||$0.04||$0.04||$55.50 million||$56.80 million||View||N/A|
|2/20/2014||Q413||$0.08||$0.11||$65.70 million||$64.30 million||View||Listen|
|11/13/2013||Q313||$0.01||$0.04||$62.06 million||$62.70 million||View||Listen|
|8/14/2013||Q2 2013||$0.09||$0.02||$70.93 million||$68.80 million||View||N/A|
|5/22/2013||Q1 2013||$0.02||$0.02||$61.19 million||$61.20 million||View||N/A|
|2/12/2013||Q4 2012||$0.09||$0.11||$70.60 million||$72.80 million||View||N/A|
|11/7/2012||Q312||$0.04||$0.03||$65.51 million||$60.13 million||View||N/A|
Earnings Estimates for Syneron Medical (NASDAQ:ELOS)
Current Year EPS Consensus Estimate: $0.38 EPS
Next Year EPS Consensus Estimate: $0.55 EPS
Dividend History for Syneron Medical (NASDAQ:ELOS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Syneron Medical (NASDAQ:ELOS)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Syneron Medical (NASDAQ:ELOS)
Latest Headlines for Syneron Medical (NASDAQ:ELOS)
Syneron Medical (ELOS) Chart for Thursday, May, 25, 2017